multigene test can predict risk of disease recurrence for women with ductal carcinoma in situ
Published 9 years ago • 235 plays • Length 14:29Download video MP4
Download video MP3
Similar videos
-
3:26
multigene test can predict risk of disease recurrence for women with ductal carcinoma in situ
-
6:51
recurrence risk could be predicted by a multigene test in ductal carcinoma breast cancer
-
1:59
dr. rakovitch on predicting risk of recurrence for women with dcis
-
5:26
improving risk prediction and decision making in dcis patients
-
21:53
dcis recurrence and radiation
-
4:31
is dcis dangerous or over-treated? how can you manage the risks?
-
2:37
breast cancer recurrence test
-
0:57
dr. schnabel discusses the dcis recurrence score
-
0:36
dr. solin on the dcis score recurrence test
-
5:39
ductal carcinoma in situ: anastrozole versus tamoxifen
-
1:33
why women with low risk of dcis may not need surgery
-
1:39
is there a test to determine the likelihood of dcis breast cancer recurrence?
-
31:53
predicting progression of dcis to invasive cancer
-
21:27
mayo clinic q&a podcast: clinical trial for ductal carcinoma in situ vaccine
-
23:34
diet and breast cancer risk | 2023 ductal carcinoma in situ patient forum
-
1:43
using dcisionrt to assess benefit of radiotherapy in patients with dcis following lumpectomy
-
0:38
clinical implications for recurrent nonclonal primary dcis
-
1:17
future advances in dcis: de-escalation of hormonal therapy
-
3:19
rakovitch: dcis score to predict breast cancer recurrence